South & Central America Myopia Treatment Market Forecast to 2030

South & Central America Myopia Treatment Market Forecast to 2030 – Regional Analysis – by Type (High Myopia, Degenerative Myopia, and Progressive Myopia), Treatment [Low-Dose Atropine Eye Drops, Contact Lenses, Ortho-K, and Refractive Surgery (LASIK and PRK)], Age Group (Adult Myopia and Childhood Myopia), and End User (Hospitals and Clinics, Specialty Clinics, and Refractive Surgery Centers)

Send Enquiry

$2,485$3,885

Description

The South & Central America myopia treatment market was valued at US$ 458.52 million in 2022 and is expected to reach US$ 676.01 million by 2030; it is estimated to register a CAGR of 5.0% from 2022 to 2030.

Rising Availability of Advanced Technologies for Treating the Targeted Myopia Fuels South & Central America Myopia Treatment Market

The rising availability of advanced technologies for treating targeted myopia is a significant opportunity for the myopia treatment market. Advances in technologies such as laser-assisted in-situ keratomileusis (LASIK), photorefractive keratectomy (PRK), and implantable collamer lenses (ICL) have made it possible to correct myopia more effectively and with fewer complications. Various ground-breaking data were also presented during the congress; over 30 abstracts backed by Johnson & Johnson Vision have been approved for presentation. Surgeons can apply the innovative SILK (i.e., Smooth Incision Lenticule Keratomileusis) treatment to treat myopic patients who have astigmatism or do not utilize the ELITATM Platform. The ELITATM Platform offers surgeons an exceptionally smooth and uncomplicated lenticular removal procedure with next-day outcomes and recovery owing to its fast laser delivery technology and ultra-precise laser pulse. These advanced technologies have traditionally been expensive and inaccessible to many patients. Still, as they become more widely available, they present an opportunity for the myopia treatment market to expand its reach and provide better treatment options to a larger patient population. In addition to these advanced technologies, other emerging treatments such as orthokeratology (ortho-k) and atropine eye drops are gaining popularity as effective methods for managing myopia. The popular orthokeratology contact lens is the latest CooperVision myopia control product to gain the CE Mark, joining EyeDream and Paragon CRT ortho-k designs, MiSight day soft contact lenses, and SightGlass Vision Diffusion Optics Technology spectacle lenses. These non-invasive treatments can be more affordable than surgical options, making them accessible to a wider range of patients. Overall, the rising availability of advanced technologies for treating targeted myopia presents a significant opportunity for the myopia treatment market. By providing patients with more effective and accessible treatment options, the market can help improve vision health outcomes and address a significant unmet need in the global healthcare landscape.

South & Central America Myopia Treatment Market Overview

South & Central America includes Argentina, Brazil, and the Rest of South & Central America. The myopia treatment market in the region is expected to have several growth opportunities. The rise in the development of the medical industry in Brazil is likely to create significant growth opportunities for market growth. Similarly, Argentina’s growing medical device industry is also expected to offer growth opportunities for the myopia treatment market.

The myopia treatment market in Brazil has witnessed significant growth due to the escalating prevalence of myopia across the country. The spread of myopia in Brazil can be attributed to various factors. Urbanization and changing lifestyles have led to increased near-work activities, such as prolonged hours spent on digital devices and reading, contributing to the development and progression of myopia. Additionally, limited outdoor activities and reduced exposure to natural light among children and adults have been linked to a higher incidence of myopia.

South & Central America Myopia Treatment Market Revenue and Forecast to 2030 (US$ Million)

South & Central America Myopia Treatment Market Segmentation

The South & Central America myopia treatment market is categorized into type, treatment, age group, end user, and country.

Based on type, the South & Central America myopia treatment market is segmented into high myopia, degenerative myopia, and progressive myopia. The high myopia segment held the largest South & Central America myopia treatment market share in 2022.

In terms of treatment, the South & Central America myopia treatment market is segmented into low-dose atropine eye drops, contact lenses, ortho-k, and refractive surgery. The low-dose atropine eye drops segment held the largest South & Central America myopia treatment market share in 2022. Furthermore, the refractive surgery segment is subcategorized into LASIK and PRK.

By age group, the South & Central America myopia treatment market is bifurcated into adult myopia and childhood myopia. The adult myopia segment held a larger South & Central America myopia treatment market share in 2022.

Based on end user, the South & Central America myopia treatment market is categorized into hospitals and clinics, specialty clinics, and refractive surgery centers. The hospitals and clinics segment held the largest South & Central America myopia treatment market share in 2022.

Based on country, the South & Central America myopia treatment market is categorized into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America myopia treatment market share in 2022.

Bausch Health Companies Inc, Alcon AG, CooperVision Inc, Johnson & Johnson Vision Care Inc, Nidek Co Ltd, and Carl Zeiss AG are some of the leading companies operating in the South & Central America myopia treatment market.

Summary Info

Industry:

Pricing options:

, ,

Geographical coverage:

,

Year of Publication:

At 5.0% CAGR, South & Central America Myopia Treatment Market is Speculated to be Worth US$ 676.01 Million by 2030, says the Research Team

According to the Research Team’ research, the South & Central America myopia treatment market was valued at US$ 458.52 million in 2022 and is expected to reach US$ 676.01 million by 2030, registering a CAGR of 5.0% from 2022 to 2030. Rising prevalence of myopia and application of artificial intelligence in myopia treatment are among the critical factors attributed to drive the South & Central America myopia treatment market growth.

Artificial intelligence (AI) is increasingly being applied in myopia treatment. One example is using AI-powered devices to monitor and analyze eye movements and visual acuity, which can help identify early signs of myopia and track its progression. AI algorithms can also be used to develop personalized patient treatment plans based on their characteristics and medical history. In the future, AI is expected to play an even greater role in myopia treatment. For instance, researchers are exploring the use of machine learning algorithms to predict children who are at high risk of developing myopia, allowing for early intervention and prevention.

Additionally, AI-powered virtual reality systems may improve visual acuity and reduce myopia progression. Thus, the myopia treatment market is expected to see continued growth and innovation in the coming years. With the increasing prevalence of myopia worldwide, there is a growing need for effective and accessible treatments. Advancements in technology, such as AI and advanced surgical techniques, are expected to drive this growth and lead to more personalized and effective treatments for myopia. Additionally, there will likely be a greater focus on preventative measures and collaboration between industry and academia to address this global health concern.

On the contrary, lack of skilled professionals hampers the growth of South & Central America myopia treatment market.

Based on type, the South & Central America myopia treatment market is segmented into high myopia, degenerative myopia, and progressive myopia. The high myopia segment held 62.4% market share in 2022, amassing US$ 286.03 million. It is projected to garner US$ 436.09 million by 2030 to register 5.4% CAGR during 2022-2030.

In terms of treatment, the South & Central America myopia treatment market is segmented into low-dose atropine eye drops, contact lenses, ortho-k, and refractive surgery. The low-dose atropine eye drops segment held 38.6% share of South & Central America myopia treatment market in 2022, amassing US$ 177.06 million. It is anticipated to garner US$ 269.97 million by 2030 to expand at 5.4% CAGR during 2022-2030. Furthermore, the refractive surgery segment is subcategorized into LASIK and PRK.

By age group, the South & Central America myopia treatment market is bifurcated into adult myopia and childhood myopia. The adult myopia segment held 65.3% share of South & Central America myopia treatment market in 2022, amassing US$ 299.28 million. It is projected to garner US$ 449.41 million by 2030 to expand at 5.2% CAGR from 2022 to 2030.

Based on end user, the South & Central America myopia treatment market is categorized into hospitals and clinics, specialty clinics, and refractive surgery centers. The hospitals and clinics segment held 65.6% share of South & Central America myopia treatment market in 2022, amassing US$ 300.71 million. It is predicted to garner US$ 454.67 million by 2030 to expand at 5.3% CAGR between 2022 and 2030.

Based on country, the South & Central America myopia treatment market is categorized into Brazil, Argentina, and the Rest of South & Central America. Our regional analysis states that Brazil captured 43.7% share of South & Central America myopia treatment market in 2022. It was assessed at US$ 200.22 million in 2022 and is likely to hit US$ 309.41 million by 2030, registering a CAGR of 5.6% during 2022-2030.

Key players operating in the South & Central America myopia treatment market are Bausch Health Companies Inc, Alcon AG, CooperVision Inc, Johnson & Johnson Vision Care Inc, Nidek Co Ltd, and Carl Zeiss AG, among others.

o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America myopia treatment market.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in the South & Central America myopia treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the South & Central America myopia treatment market, as well as those hindering it
o Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.
TABLE OF CONTENTS

1. Introduction
1.1 The the Reporting Teams Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central America Myopia Treatment Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Market Share Analysis, By Companies
5. South & Central America Myopia Treatment Market – Key Market Dynamics
5.1 South & Central America Myopia Treatment Market – Key Market Dynamics
5.2 Market Drivers
5.2.1 Rising Prevalence of Myopia
5.2.2 Increased Awareness of Myopia Treatment
5.3 Market Restraints
5.3.1 Lack of Skilled Professionals
5.4 Market Opportunities
5.4.1 Rising Availability of Advanced Technologies for Treating The Targeted Myopia
5.5 Future Trends
5.5.1 Application of Artificial Intelligence in Myopia Treatment
5.6 Impact of Drivers and Restraints:
6. Myopia Treatment Market – South & Central America Market Analysis
7. South & Central America Myopia Treatment Market Analysis – by Type
7.1 High Myopia
7.1.1 Overview
7.1.2 High Myopia: South & Central America Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
7.2 Degenerative Myopia
7.2.1 Overview
7.2.2 Degenerative Myopia: South & Central America Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
7.3 Progressive Myopia
7.3.1 Overview
7.3.2 Progressive Myopia: South & Central America Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
8. South & Central America Myopia Treatment Market Analysis – by Treatment
8.1 Low-Dose Atropine Eye Drops
8.1.1 Overview
8.1.2 Low-Dose Atropine Eye Drops: South & Central America Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
8.2 Refractive Surgery
8.2.1 Overview
8.2.2 Refractive Surgery: South & Central America Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
8.2.3 LASIK
8.2.4 PRK
8.3 Contact Lenses
8.3.1 Overview
8.3.2 Contact Lenses: South & Central America Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Ortho-K
8.4.1 Overview
8.4.2 Ortho-K: South & Central America Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
9. South & Central America Myopia Treatment Market Analysis – by Age Group
9.1 Adult Myopia
9.1.1 Overview
9.1.2 Adult Myopia: South & Central America Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
9.2 Childhood Myopia
9.2.1 Overview
9.2.2 Childhood Myopia: South & Central America Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
10. South & Central America Myopia Treatment Market Analysis – by End User
10.1 Hospitals and Clinics
10.1.1 Overview
10.1.2 Hospitals and Clinics: South & Central America Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
10.2 Specialty Clinics
10.2.1 Overview
10.2.2 Specialty Clinics: South & Central America Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
10.3 Refractive Surgery Centers
10.3.1 Overview
10.3.2 Refractive Surgery Centers: South & Central America Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
11. South & Central America Myopia Treatment Market – Country Analysis
11.1 Overview
11.2 South & Central America
11.2.1 South & Central America: Myopia Treatment Market – Revenue and Forecast Analysis – by Country
11.2.1.1 South & Central America: Myopia Treatment Market – Revenue and Forecast Analysis – by Country
11.2.1.2 Brazil
11.2.1.3 Brazil: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
11.2.1.3.1 Brazil: Myopia Treatment Market Breakdown, by Type
11.2.1.3.2 Brazil: Myopia Treatment Market Breakdown, by Treatment
11.2.1.3.3 Brazil: Myopia Treatment Market Breakdown, by Refractive Surgery
11.2.1.3.4 Brazil: Myopia Treatment Market Breakdown, by Age Group
11.2.1.3.5 Brazil: Myopia Treatment Market Breakdown, by End User
11.2.1.4 Argentina
11.2.1.5 Argentina: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
11.2.1.5.1 Argentina: Myopia Treatment Market Breakdown, by Type
11.2.1.5.2 Argentina: Myopia Treatment Market Breakdown, by Treatment
11.2.1.5.3 Argentina: Myopia Treatment Market Breakdown, by Refractive Surgery
11.2.1.5.4 Argentina: Myopia Treatment Market Breakdown, by Age Group
11.2.1.5.5 Argentina: Myopia Treatment Market Breakdown, by End User
11.2.1.6 Rest of South & Central America
11.2.1.7 Rest of South & Central America: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
11.2.1.7.1 Rest of South & Central America: Myopia Treatment Market Breakdown, by Type
11.2.1.7.2 Rest of South & Central America: Myopia Treatment Market Breakdown, by Treatment
11.2.1.7.3 Rest of South & Central America: Myopia Treatment Market Breakdown, by Refractive Surgery
11.2.1.7.4 Rest of South & Central America: Myopia Treatment Market Breakdown, by Age Group
11.2.1.7.5 Rest of South & Central America: Myopia Treatment Market Breakdown, by End User
12. Industry Landscape
12.1 Overview
12.2 Growth Strategies in Myopia Treatment Market
12.3 Organic Growth Strategies
12.3.1 Overview
12.4 Inorganic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 Bausch Health Companies Inc
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Alcon AG
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 CooperVision Inc
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Johnson & Johnson Vision Care Inc
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Nidek Co Ltd
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Carl Zeiss AG
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
14. Appendix
14.1 About The the Reporting Teams
14.2 Glossary of Terms

LIST OF TABLES

Table 1. South & Central America Myopia Treatment Market Segmentation
Table 2. Market Share (~) by Companies in the Global Myopia Treatment Market (%)
Table 3. South & Central America Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by Type
Table 4. South & Central America Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by Treatment
Table 5. South & Central America Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by Age Group
Table 6. South & Central America Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by End User
Table 7. South & Central America: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by Country
Table 8. Brazil: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by Type
Table 9. Brazil: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by Treatment
Table 10. Brazil: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by Refractive Surgery
Table 11. Brazil: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by Age Group
Table 12. Brazil: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by End User
Table 13. Argentina: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by Type
Table 14. Argentina: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by Treatment
Table 15. Argentina: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by Refractive Surgery
Table 16. Argentina: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by Age Group
Table 17. Argentina: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by End User
Table 18. Rest of South & Central America: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by Type
Table 19. Rest of South & Central America: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by Treatment
Table 20. Rest of South & Central America: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by Refractive Surgery
Table 21. Rest of South & Central America: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by Age Group
Table 22. Rest of South & Central America: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million) – by End User
Table 23. Recent Organic Growth Strategies in Myopia Treatment Market
Table 24. Recent Inorganic Growth Strategies in the Myopia Treatment Market
Table 25. Glossary of Terms, Myopia Treatment Market

LIST OF FIGURES

Figure 1. South & Central America Myopia Treatment Market Segmentation, by Country
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. South & Central America Myopia Treatment Market Revenue (US$ Million), 2020-2030
Figure 5. South & Central America Myopia Treatment Market Share (%) – by Type (2022 and 2030)
Figure 6. High Myopia: South & Central America Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Degenerative Myopia: South & Central America Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Progressive Myopia: South & Central America Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. South & Central America Myopia Treatment Market Share (%) – by Treatment (2022 and 2030)
Figure 10. Low-Dose Atropine Eye Drops: South & Central America Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Refractive Surgery: South & Central America Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. LASIK: South & Central America Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. PRK: South & Central America Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Contact Lenses: South & Central America Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Ortho-K: South & Central America Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. South & Central America Myopia Treatment Market Share (%) – by Age Group (2022 and 2030)
Figure 17. Adult Myopia: South & Central America Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Childhood Myopia: South & Central America Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. South & Central America Myopia Treatment Market Share (%) – by End User (2022 and 2030)
Figure 20. Hospitals and Clinics: South & Central America Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Specialty Clinics: South & Central America Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Refractive Surgery Centers: South & Central America Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. South & Central America: Myopia Treatment Market, by Key Country – Revenue (2022) (US$ Million)
Figure 24. South & Central America: Myopia Treatment Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 25. Brazil: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 26. Argentina: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 27. Rest of South & Central America: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 28. Growth Strategies in Myopia Treatment Market

The List of Companies – South & Central America Myopia Treatment Market

1. Bausch Health Companies Inc
2. Alcon AG
3. CooperVision Inc
4. Johnson & Johnson Vision Care Inc
5. Nidek Co Ltd
6. Carl Zeiss AG

Reviews

There are no reviews yet.

Be the first to review “South & Central America Myopia Treatment Market Forecast to 2030”